Minimizing Toxicity While Maintaining Efficacy in RCC

EP. 1: Introduction: Multidisciplinary Frontline Treatment of mRCC

March 19th 2014

EP. 2: Treatment of Metastatic Non-Clear Cell RCC

March 19th 2014

EP. 3: Frontline Treatment of Poor-Risk mRCC

March 19th 2014

EP. 4: Cytoreductive Nephrectomy in Untreated Metastatic RCC

March 19th 2014

EP. 5: Optimizing the Upfront Treatment of mRCC

March 19th 2014

EP. 6: Second-Line Treatment of Metastatic Renal Cell Carcinoma

March 19th 2014

EP. 7: Second-Line Angiogenesis Inhibition in mRCC

March 19th 2014

EP. 8: Case Study: Treating Progressive Renal Cell Carcinoma

March 19th 2014

EP. 9: Case Study: Observation in Metastatic RCC

March 19th 2014

EP. 10: Drug Holidays in Renal Cell Carcinoma

March 19th 2014

EP. 11: Case Study: Utilizing Multiple Therapies in mRCC

March 19th 2014

EP. 12: Evolving Role of Genomic Testing in RCC

March 19th 2014

EP. 13: Novel Therapies in Renal Cell Carcinoma

March 19th 2014

EP. 14: RCC Journal Highlights and Implications for Clinical Practice

March 19th 2014

EP. 15: Conclusion: Optimizing the Treatment of RCC

March 19th 2014